Dr. Martin Hofmann, MD

Dr. Hofmann practices at Charms Property Incorporated in Redlands, California.

Dr. Hofmann's NPI, 1831586783, was assigned on April 17, 2015. Dr. Hofmann graduated from UC Irvine School of Medicine in 2014. Dr. Hofmann holds California license A144764.

Dr. Hofmann's primary practice is Charms Property Incorporated, at 245 Terracina Blvd, Redlands, CA 92373 in San Bernardino County. The practice phone is (909) 307-0900.

Dr. Hofmann's primary practice is Charms Property Incorporated in Redlands, California. Dr. Hofmann is also affiliated with Redlands Community Hospital. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Hofmann to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hofmann practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hofmann's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hofmann is board certified in urology by the American Board of Urology. Dmand AI has Dr. Hofmann's licenses on file in 2 states: California and Ohio.

Dmand AI lists bladder removal, enlarged prostate, erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Hofmann treats.

CMS data shows 398 Medicare services from Dr. Hofmann across 11 procedure codes in 2024, for 243 Medicare patients. Medicare paid $33,603 for them. Every service was in an office.

CMS counts 243 Medicare patients who saw Dr. Hofmann in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hofmann's median patient age at 69, with 20% women.

In 2024, Dr. Hofmann wrote 784 Medicare Part D claims for 262 patients. 94% of them were for generic drugs. CMS names the drug for 641 of them, across 18 drugs with 11 or more claims each, at $19,703 in total drug cost. In 2023, CMS named 496 claims across 16 drugs.

Dr. Hofmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hofmann as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Hofmann, published from 2014 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Kidney Neoplasms and Laparoscopy. Dr. Hofmann has published most often in Urology. Dr. Hofmann's most frequent co-authors are Jaime Landman, MD, Philip Laurence Bucur, MD and Steven Campbell, MD.

CMS Open Payments shows 16 general payments to Dr. Hofmann from 10 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Edap Technomed Inc paid the most, $283.

Dr. Hofmann graduated from UC Irvine School of Medicine in 2014. Dr. Hofmann is a member of American Urological Association, European Association of Urology and Society of Urologic Oncology.

Dr. Hofmann is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.